Recent Press Coverage
01/20/10 Xconomy — "Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial"
December 2009 Optometry Times — "Potential Dry AMD Treatment Slows Visual Cycle to Prolong Eye Health"
November/December 2009 Retinal Physician — "Preclinical and Phase 1 Drugs in Development for Dry AMD: An Overview"
November/December 2009 PharmaVOICE — "What's in Store for 2010"
November/December 2009 PharmaVOICE — "Reform, Consolidation and Good Citizenry"
November/December 2009 PharmaVOICE — "Addressing the Innovation Challenge"
November 2009 Seattle Business Magazine — "Top 25 Innovators & Entrepreneurs"
11/02/09 MIT Technology Review — "Molecular Sunglasses for Macular Degeneration"
September 2009 EyeNet Magazine — "Dry AMD: Under Attack on Four Fronts"
09/28/09 Chemical & Engineering News — "Gaining Focus: Small-molecule drugs to treat dry age-related macular degeneration are heading to the clinic"
August 2009 Japan External Trade Organization (JETRO) — Profile of Acucela
08/10/09 Xconomy “Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.”
July/August 2009 Start-Up — “Acucela Inc. Pursuing new targets for treating blinding eye diseases”
06/25/09, Vol 2, No 25, SciBX — “Seeing CNV sooner”
03/10/09 King 5 News — Pill holds promise for macular degeneration treatment